By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Koronis Pharmaceuticals, Inc. 

12277 134th Court NE
Suite 110
Redmond  Washington  98052  U.S.A.
Phone: 425-825-0240 Fax: 425-825-7470


SEARCH JOBS








Company News
U.S. HIV Drug Firm Koronis Pharmaceuticals, Inc. Looks to London Listing 3/14/2011 6:36:39 AM
Koronis Pharmaceuticals, Inc. Clinical Trial Results Demonstrate Promise for First Non-suppressive HIV Drug 1/20/2011 10:40:11 AM
Koronis Pharmaceuticals, Inc. Announces Late-Breaker Oral Presentation on HIV Therapeutic Candidate KP-1461 at 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 9/9/2010 11:55:00 AM
Koronis Pharmaceuticals, Inc. to Present at 2010 Biotechnology Industry Organization (BIO) International Convention 4/29/2010 10:55:54 AM
Koronis Pharmaceuticals, Inc.' Scientific Advisory Board Confirms KP-1461 Clinical Drug Activity, HIV Ablation 5/19/2009 8:59:12 AM
Koronis Pharmaceuticals, Inc. Suspends HIV Trials, Seeks Series E 10/13/2008 9:49:55 AM
Koronis Pharmaceuticals, Inc. Announces Appointment Of Prominent HIV Researcher Courtney Fletcher, Pharm. D., To Scientific Advisory Board And Jeff Parkins As VP, Clinical Development 9/30/2008 9:24:06 AM
Koronis Pharmaceuticals, Inc. Appoints David Drajeske Director of Business Development 2/7/2008 7:57:35 AM
Koronis Pharmaceuticals, Inc. Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors 1/31/2008 9:07:40 AM
Koronis Pharmaceuticals, Inc. Announces Issuance of U.S. Patent for KP-1461 Therapeutic in Development for Treatment of HIV 7/23/2007 8:44:53 AM
12
//-->